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1. Introduction  
The term “lectin” was coined by William Boyd in 1954 from the Greek word “legere” which 
means “to select” or “to bind”. Lectins and hemagglutinins are proteins/glycoproteins of 
non-immune origin, which have at least one non-catalytic domain that exhibits reversible 
binding to specific monosaccharides or oligosaccharides (Lis and Sharon, 1986). The lectin-
monosaccharide interactions are relatively very weak and the dissociation constants lie in 
millimolar range. However, in nature for the multimeric sugars the dissociation constants 
are several folds higher indicating that multiple protein-carbohyrate interactions are 
involved in the recognition and binding events (Ambrosi et al., 2005). Thus, lectins are 
multivalent in nature and can bind to the carbohydrate moieties on the surface of 
erythrocytes and agglutinate the erythrocytes, without altering the properties of the 
carbohydrates (Lam and Ng, 2011). Lectins are ubiquitous and are extensively distributed in 
nature. Many hundreds of these lectins have been isolated from varied sources like plants, 
viruses, bacteria, invertebrates and vertebrates but in all, lectins from different sources show 
little similarity. Lectins are invaluable tools for the detection, isolation, and characterization 
of glycoconjugates, primarily of glycoproteins, for histochemistry of cells and tissues and for 
the examination of changes that occur on cell surfaces during physiological and pathological 
processes, from cell differentiation to cancer (Sharon and Lis, 2004). 
 
Cell identification and separation 
Detection, isolation, and structural studies of glycoproteins 
Investigation of carbohydrates on cells and subcellular organelles; histochemistry and 
cytochemistry 
Mapping of neuronal pathways 
Mitogenic stimulation of lymphocytesb 
Purging of bone marrow for transplantationb 
Selection of lectin-resistant mutants 
Studies of glycoprotein biosynthesis 
a Lectins from sources other than plants are rarely in use. 
b In clinical use. 
Source: Sharon and Lis, 2004 
Table 1. Major applications of lectinsa 
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Lectin Category Definition 
Merolectins Proteins that consist exclusively of a single carbohydrate-binding 
domain. They are small, single-polypeptide proteins that are 
incapable of agglutinating cells because of their monovalent nature. 
Hololectins These are composed exclusively of carbohydrate binding domains, 
but contain at least two such domains. 
Chimerolectins These are fusion proteins composed of one or more carbohydrate-
binding domains and an unrelated domain with a well-defined 
biological activity. Based on the number of sugar-binding sites, 
chimerolectins behave as either merolectins or homolectins. 
Source: Van Damme and Peumans, 1996. 
Table 2. Classification of lectins  
 
Lectin name Family Glycan ligands 
Plant lectins   
Concanavalin A (Con A; jack bean) Leguminosae Man/Glc 
Wheat germ agglutinin (WGA; wheat) Gramineae (GlcNAc)1–3, Neu5Ac 
Ricin (castor bean) Euphorbiaceae Gal 
Phaseolus vulgaris (PHA; French bean) Leguminosae None known 
Peanut agglutinin (PNA; peanut) Leguminosae Gal, Galb3GalNAca 
(T-antigen) 
Soybean agglutinin (SBA; soybean) Leguminosae Gal/GalNAc 
Pisum sativum (PSA; pea) Leguminosae Man/Glc 
Lens culinaris (LCA; lentil) Leguminosae Man/Glc 
Galanthus nivalus (GNA; snowdrop) Amaryllidaceae Man 
Dolichos bifloris (DBA; horse gram) 
Leguminosae 
 GalNAca3GalNAc, 
GalNAc 
Solanum tuberosum (STA; potato)   (GlcNAc)n 
Animal lectins    
Asialoglycoprotein receptor 
(ASGPR) H1 
 C-type Gal 
Galectin-3  galectins Gal 
Sialoadhesin  I-type Neu5Ac 
Cation-dependent mannose-6-
phosphate receptor (CD-MPR) 
 P-type Man6P 
C-reactive protein 
(CRP) 
 Pentraxins Gal, Gal6P, 
galacturonic acid 
Source: Ambrosi et al., 2005 
Table 3. Examples of lectins, the families to which they belong and their glycan ligand 
specificities 
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Lectins are often classified based on saccharide-specificity. Though this conventional 
method is familiar and practically useful, it is not necessarily relevant for refined specificity. 
Lectins in the same category (e.g., galactose-specific lectins) show considerably different 
sugar-binding preferences. Moreover, an increasing number of lectins which never show 
high affinity to simple saccharides have been found. They can also be categorized according 
to the overall structures into merolectins, hololectins, chimerolectins and superlectins, or be 
grouped into different families (legume lectins, type II ribosome-inactivating proteins, 
monocot mannose-binding lectins, and other lectins). 
The first protein showing inhibition of microorganisms was isolated from wheat flour in 
1942 (Balls et al., 1942). However, it was found as late as 1980 by Duguid that E. coli 
possesses the ability to agglutinate erythrocytes and this ability is inhibited by mannose and 
methyl a-mannoside. Erzler in 1986 reported that lectins in higher plants defend against 
pathogenic bacteria and fungi by recognizing and immobilizing the infecting 
microorganisms via binding, thereby preventing their subsequent growth and 
multiplication. The role of lectins as those of the herbaceous Amaranthus in inhibiting 
bacteria and fungi has long been known (Bolle et al., 1996). Microbes have lectins that help 
in recognition and the blocking of these can prevent the infection has been established in 
mouse models. However, success of such treatments in humans has not been achieved yet 
(Sharon, 2006). Lately, with the emerging problem of multiple drug resistance, research in 
characterization of newer lectins to combat infections is gaining momentum. 
2. Lectins as tools in cell recognition 
Lectins agglutinate cells and react with the glycoconjugates present on their surface. Cells 
at different stages of growth and differentiation express different glycoconjugates on their 
surface and this made lectins an important tool to investigate the cell pathology and 
physiology. James Sumner in 1919 isolated concanavalin A in crystalline form and in 1936, 
together with Howell, reported that it agglutinates cells such as erythrocytes and yeasts 
and that this agglutination is inhibited by sucrose, thus demonstrating for the first  
time the sugar specificity of lectins. Walter Morgan and Winifred Watkins in the early 
1950s used blood type-specific hemagglutinins to show that the blood type A 
immunodeterminant is ǂ-linked N-acetylgalactosamine and that the H(O) determinant is 
ǂ-L-fucose. This was the first demonstration that cell surface carbohydrates can serve as 
carriers of biological information.  
Several basic features of membranes were revealed, or their existence confirmed, with the 
aid of lectins. Singer and Nicolson using ferritin-conjugated concanavalin A and ricin as an 
electron microscopic probe found that the lectin derivatives bind specifically to the outer 
surface of the human and rabbit erythrocyte membrane and concluded that the 
oligosaccharides of the plasma membrane of eukaryotic cells are asymmetrically distributed 
(1971). Vincent Marchesi used ferritin-labeled phytohemagglutinin (PHA) and showed that 
glycophorin is oriented in such a way that its carbohydrate-carrying segment is exposed to 
the external medium, whereas the other segments of the same molecule are embedded in the 
lipid bilayer or protrude into the cytoplasm (Sharon, 2007). 
It was later found that lectin-induced clustering and patching of the corresponding 
membrane receptors on lymphocytes and other kinds of cell, as illustrated for example by 
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the treatment with fluorescein-labeled concanavalin A of rat or mouse lymphocytes (Inbar 
and Sachs, 1973). Reorganization of cell surface carbohydrates was later shown to be 
required for various activities of lectins on cells such as mitogenic stimulation and induction 
of apoptosis. There is increasing evidence that changes in cellular glycosylation attend 
alterations in cell behaviour in both normal and in pathological processes, and that this may 
be of particular interest in malignancy. The malignant cells differ from the normal cells in 
the distribution of carbohydrates on the outer surface; many of these have an affinity for 
lectins (Brooks et al., 2001, Kannan et al., 2003). The reports of Inbar and Sachs also proved 
that lectins agglutinated malignantly transformed cells but not their normal parental cells 
(1973). They provided compelling evidence that cancer might be associated with a change in 
cell surface sugars, an idea that only a few years before had been considered completely 
unfounded. It was also found that SBA (specific for galactose and N-acetylgalactosamine) 
also possesses the remarkable ability to distinguish between normal and malignant cells 
(Sharon, 2007). Numerous subsequent studies have demonstrated that high susceptibility to 
agglutination by lectins is a property shared by many, albeit not all, malignant cells. The 
herbal Viscum album (Mistletoe) lectin (ML-1), has been shown to have antitumoral activity 
because of its ability to modulate and activate natural killer cells (Joshi, S, 1993). ML-1 also 
induces apoptosis in myelomonocytic leukemia (Joshi, S et al., 1994). Another herbal 
medicine Agaricus bisporus lectin (ABL), has also been shown to reverse the proliferation of 
colorectal and breast cancer cells in humans (Yu L et al., 1983). 
Bacterial lectins are typically elongated submicroscopic multi-protein appendages, known 
as fimbriae (or pili) which mediate their adhesion to glycocalyx. Adhesion appears to 
prevent bacterium removal by intestinal peristalsis, facilitating colonization of the small 
intestine. Lectins from human pathogens like E.coli, Actinomyces naeslundii, C. jejuni, E. 
cloacae, H. influenzae, H. pylori, K. pneumoniae, N. gonorrhoea, N. meningitides, S. mutans and P. 
aeruginosa with diverse specificities have been isolated and characterized. An individual 
bacterium may co-express more than one lectin, e.g., certain strains of E. coli are both 
mannose and galabiose specific and those of H. pylori recognize simultaneously the tri- and 
tetrasaccharide. The major function of the enterobacterial surface lectins, as that of similar 
lectins of other microorganisms, is to mediate the adhesion of the organisms to host cells, an 
initial stage of infection. This has been extensively demonstrated both in vitro, in studies 
with isolated cells and cell cultures, and in vivo in experimental animals, and is supported 
in some cases also by clinical data. It is best documented for E. coli type 1 and P fimbriae 
(Bergsten et al., 2005). P-fimbriae have been shown to enhance the early establishment of E. 
coli in the human urinary tract, and a strong association has been found between the 
presence of P-fimbriae with disease severity, suggesting that adherence mediated by these 
organelles has a direct effect on mucosal inflammation in vivo (Sauer et al., 2000). 
Concerning the type 1 fimbriae, it has been reported that mutants of E. coli deficient in Fim 
H, the carbohydrate-binding subunit of the fimbriae, are unable to cause cystitis in monkeys 
(Sauer et al., 2000). Attachment of a pathogen to a tissue does not of itself initiate disease. It 
must be coupled to specific responses that lead to infection. Adherence of P-fimbriated E. 
coli or of the isolated P fimbriae to galabiose of uroepithelial cells induces a two-way flow of 
biological crosstalk via the lectin bridge, affecting both partners. Following adherence, the 
target cells are activated, with resultant production of cytokines that engender acute 
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inflammation and other symptoms of disease, while in the bacteria the interaction leads to 
up-regulation of signal transduction systems that allow responses to the changing 
environment (Sharon, 2006).  
The FimH subunits of both E. coli and K. pneumoniae are 88% homologous, yet they have 
different specificities (Gupta et al., 2009). They mediate not only bacterial adhesion, but also 
invasion of human bladder and intestinal, respectively. In contrast, adhesion mediated by 
PapG, the lectin subunit of P fimbriae, did not initiate bacterial internalization. E. coli strains 
that cause urinary tract infections are not strictly extracellular pathogens and FimH can 
directly trigger host cell signalling cascades that lead to bacterial internalization. Type 1 
fimbriae are instrumental also in the attachment of E. coli to human polymorphonuclear cells 
and human and mouse macrophages, in the absence of opsonins. This is often followed by 
the ingestion and killing of the bacteria, a phenomenon named “lectinophagocytosis” (Ofek 
and Sharon, 2000), an early example of innate immunity; it may function in vivo, for 
example in sites poor in opsonins, and in the peritoneal cavity. Indeed, injection of type 1 
fimbriated E. coli into the peritoneal cavity of mice led to the activation of the peritoneal 
macrophages; no activation was observed in the presence of methyl ǂ-mannoside or when 
non-fimbriated bacteria were used (Bernhard et al., 1992). Enterobacteria can attach by their 
surface lectins to mast cells as well, with resultant activation of the target cells and 
production of high levels of certain cytokines, in particular TNF-ǂ (Malviya and Abraham, 
2001). Activation of mast cells can also be induced by purified type 1 fimbriae, and by FimH. 
The cytokines released by the activated mast cells cause rapid recruitment of neutrophils 
into the site of infection, resulting in early clearance of the bacteria. As expected, mice 
lacking mast cells were significantly less efficient in clearing intranasal or intraperitoneal 
infection caused by K. pneumoniae.  
Specific binding of lectin to Chlamydial cell wall structures is demonstrated by the binding 
of Galanthus nivalis lectin (GNA). Binding of sialic acid residues to peanut agglutinin 
(PNA), and jackfruit lectin (JFL), were also found in two Chlamydial glycopeptides 
(Siridewa, et al., 1993). The study suggests that lectins may be of use as therapeutic agents to 
keep Chlamydial organisms from entering human cells, thus rendering them more 
susceptible to immune system elimination.  
3. Antibacterial effect of lectins 
3.1 Direct inhibition of lectin 
Quite recently novel lectins are usually tested for any potential antimicrobial activity. A 
novel galactoside binding lectin from Bothrops leucurus snake venom was purified and it 
exhibited antibacterial effect against the human pathogenic Gram positive bacteria 
Staphylococcus aureus, Enterococcus faecalis and Bacillus subtilis (Nunes et al., 2011). 
Archidendron jiringa seed lectin showed inhibitory activity against B. subtilis and S. aureus but 
did not show any activity against E.coli and P. aeruginosa (Charungchitrak et al., 2010). 
Lectins have been islated from serum, plasma, skin mucus and egg of fishes (Jensen et al., 
1997;, Ottinger et al., 1999; Dong et al., 2004; Tasumi et al., 2004). A galactose binding lectin 
has been isolated from Indian catfish Clarias batrachus. The lectin agglutinated E.coli, P 
aeruginosa and Klebsiella strains (Dutta et al., 2005). 
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Plant (tissue) Lectin 
specificity 
Antibacterial activity 
Eugenia uniflora
(seeds) 
 
 
Carbohydrate  
complex  
Bacillus subtilis, Corynebacterium bovis, 
Escherichia coli, Klebsiella sp.,  
Pseudomonas aeruginosa,  
Streptococcus sp., Staphylococcus aureus 
Myracrodruon 
urundeuva 
(heartwood) 
GlcNAc B. subtilis, Corynebacterium callunae, E. coli, 
Klebsiella  pneumoniae, P. aeruginosa, S. aureus, 
Streptococcus faecalis. 
Phthirusa pyrifolia
(leaf) 
Fru-1,6-P2 B. subtilis, K. pneumoniae,  
Staphylococcus epidermidis,  
S. faecalis 
Table 4. Lectins with antibacterial activity, Source: Paiva et al., 2010. 
3.2 Lectins against the virulence properties of pathogenic bacteria 
The use of lectins in antiadhesion therapy has already been proposed in the literature (Ofek 
et al., 2003; Mody et al., 2005).This may be of particular importance for controlling diseases 
where opportunistic pathogens are involved and bacterial adhesion is critical, followed by 
attainment of sedentary mode of bacterial lifestyle (biofilms) like in oral infections. The 
acquired enamel pellicle is an organic and acellular film formed by selective adsorption of 
salivary molecules to the teeth (Yin et al., 2005). Oral bacteria adhere to this pellicle during 
the initial events of dental plaque formation (Saxton 1973; Yao et al., 2001), a crucial event to 
dental caries, pathology that represents a health expenditure of several billion dollars per 
year in the United States alone (Global Oral Health 2006). As bacterial adhesion to the 
acquired pellicle is one of the primary stages of plaque formation which may lead to caries 
(Scheie, 1994), it is reasonable to suppose that avoiding adhesion could be a good method to 
prevent this disease at early stages. Lectins may be good candidates to carry out this 
approach, as the adherence of bacteria to host cells is, in many cases, mediated by lectin-like 
adhesins on the bacterial surface that recognize carbohydrate receptors (Ofek and Sharon 
1990; Hytonen et al., 2000). Marine algal lectins are especially interesting for biological 
applications because they have generally lower molecular masses as compared with most 
land plant lectins. An additional benefit might be that small algal lectin molecules may be 
expected to be less antigenic than the larger land plant lectins (Rogers and Hori, 1993). 
Further, they possess great stability on account of their several disulfide bridges and present 
high specificity for complex carbohydrates and glycoconjugates, especially for mucins 
(Ainouz et al., 1995; Sampaio et al., 1998; Nagano et al., 2005). The ability of two algal lectins 
BSL and BTL to bind to the SHA beads and their effectiveness in decreasing the adhesion of 
streptococci to the pellicle: BSL showed statistically significant results (<0·01), especially for 
S. mutans, whose adhesion was decreased almost totally; while BTL achieved this type of 
result for only two strains (S. sobrinus and S. mitis) (Teixeira et al., 2007) 
The streptococcal cell wall contains four major antigenic polymers: peptidoglycan, group 
and type-specific polysaccharides, proteins and the glycerol form of teichoic and lipoteichoic 
acids. We studied lectins from edible sources and different specificities to the different 
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components of the cell wall of oral pathogen, Streptococcus mutans. Lectins from Canavalia 
ensiformis (ConA), Trigonella foenumgraecum (TFA), Triticum aestivum (WGA), Arachis 
hypogaea (PNA), Cajanus cajan (CCL), Phaseolus vulgaris (PHA) and Pisum sativum (PSA) were 
tested against the growth and biofilm formation of S. mutans on saliva coated surface. None 
of these lectins inhibit the bacterial growth even up to a concentration of 1000mg/ml. 
However, all the lectins inhibited the biofilm formation by S.mutans in-vitro. Amongst these, 
lectins with Mannose/Glucose (ConA, TFA, CCL and PSA) specificity showed the highest 
inhibitory effect on the biofilm formation while lectins with N-acetylglucosamine specificity 
(WGA and PHA) and N-acetylgalactosamine specificity (PNA) also showed inhibition, 
albeit to a lesser degree (Islam et al., 2009).  
 
Organism Target tissue Carbohydrate For
mb 
C. jejunic Intestinal Fucǂ2GalǃGlcNAc GP 
E. coli Type 1 Urinary Manǂ3Manǂ6Man GP 
P Urinary Galǂ4Gal GSL 
S Neural NeuAc (ǂ2–3)Galǃ3GalNAc GSL 
CFA/1 Intestinal NeuAc (ǂ2–8)– GP 
F1Cd Urinary GalNAcǃ4Galǃ GSL 
F17e Urinary GlcNAc GP 
K1 Endothelial GlcNAcǃ4GlcNAc GP 
K99 Intestinal NeuAc(ǂ2–3)Galǃ4Glc GSL 
H. influenzae Respiratory [NeuAc(ǂ2–3)]0,1Galǃ4GlcNAcǃ3Galǃ4GlcNAc GSL 
H. pylori Stomach NeuAc(ǂ2–3)Galǃ4GlcNAc GP 
  Fucǂ2Galǃ3(Fucǂ4)Gal GP 
K. pneumoniae Respiratory Man GP 
N. gonorrhoea Genital Galǃ4Glc(NAc) GSL 
N. meningitidis Respiratory [NeuAc(ǂ2–3)]0,1Galǃ4GlcNAcǃ3Galǃ4GlcNAc GSL 
P. aeruginosaf Respiratory L-Fuc GP 
 Respiratory Galǃ3Glc(NAc)ǃ3Galǃ4Glc GSL 
S. typhimurium Intestinal Man GP 
S. pneumoniae Respiratory [NeuAc(ǂ2–3)]0,1Galǃ4GlcNAcǃ3Galǃ4GlcNAc GSL 
S. suis Respiratory Galǂ4Galǃ4Glc GSL 
Source: Gupta et al., 2009. 
Table 5. Carbohydrates as attachment sites for bacterial pathogens on animal tissuesa 
A surface glycoprotein of S.mutans of 60 kDa (with mannose and N-acetylgalactosamine) 
has been known to involve in saliva and bacterial interaction. The lesser adherence in the 
presence of glucose/mannose and galactosamine specific lectins could be because of the 
interaction with this protein. The PHA and WGA lectin binds to a constituent of the 
peptidoglycan of the cell wall (Sharon and Lis 2003). The attachment of bacteria is mediated 
by glucan binding lectin (GBL) and the presence of lectin in the growth media perhaps leads 
to competition between GBL of bacteria and plant lectins for the attachment sites on salive-
coated plates resulting in less binding of the cells. With regard to bacterial surface lectins 
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that often play a role in the initial step of adherence, plant lectins by interfering in this 
process show a promising future as anti-adherence agents (Islam et al., 2009). A schematic 
description of how lectins might inhibit attachment of bacteria to the host tissue is shown in 
Figure 1 (Ghazarian et al., 2011). 
Use of bacterial lectin inhibitors such as mannose to prevent the adhesion of Eschericia coli to 
bladder epithelial cells has been employed in clinical practice for some time. Other 
bioglycans, such as that from Crenomytalus grayanus (mussels), has been found to 
considerably decrease the adhesion of the bacteria Eschericia coli, Staphylococcus aureus and 
Pseudomonas aeruginosa (Zaporozhets et al., 1994). Plant lectins such as those from Datura 
stramonium, Robinia pseudoacacia and Dolichos biflorus agglutinated Streptococcal Group C 
bacterial cells (Kellens et al., 1994) which prevents them from adhering to human cell 
surfaces.  
4. Antiviral effect of lectin  
The surfaces of retroviruses such as human immunodeficiency virus (HIV) and many other 
enveloped viruses are covered by virally-encoded glycoproteins. Glycoproteins gp120 and 
gp41 present on the HIV envelope are heavily glycosylated, with glycans estimated to 
contribute almost 50% of the molecular weight of gp120 (Mizuochi et al., 1988; Ji et al., 2006). 
The antiviral activity of lectins appears to depend on their ability to bind mannose-
containing oligosaccharides present on the surface of viral envelope glycoproteins. Agents 
that specifically and strongly interact with the glycans may disturb interactions between the 
proteins of the viral envelope and the cells of the host (Botos & Wlodawer, 2005; Balzarini, 
2006). Sugar-binding proteins can crosslink glycans on the viral surface (Sacchettini et al., 
2001; Shenoy et al., 2002) and prevent further interactions with the co-receptors. Unlike the 
majority of current antiviral therapeutics that act through inhibition of the viral life cycle, 
lectins can prevent penetration of the host cells by the viruses. Antiviral lectins are best 
suited to topical applications and can exhibit lower toxicity than many currently used 
antiviral therapeutics. Additionally, these proteins are often resistant to high temperatures 
and low pH, as well as being odorless, which are favorable properties for potential 
microbicide drugs. Antiviral activity of a number of lectins that bind high-mannose 
carbohydrates has been described in the past. Examples of such lectins include jacalin 
(O’Keefe et al., 1997), concanavalin A (Hansen et al., 1989), Urtica diocia agglutinin 
(Balzarini et al., 1992), Myrianthus holstii lectin (Charan et al., 2000), and Narcissus 
pseudonarcissus lectin (Balzarini et al., 1991). However, lectins derived from marine 
organisms, a rich source of natural antiviral products (Tziveleka et al., 2003), such as CV-N 
(Boyd et al., 1997), SVN (Bokesch et al., 2003), MVL (Bewley et al., 2004) and GRFT (Mori et 
al., 2005), exhibit the highest activity among the lectins that have been investigated so far 
(Ziółkowska NE and Wlodawer A 2006). Some lectins found in algae, such as cyanovirin-N 
(CV-N) (Boyd et al., 1997; Esser et al., 1999; Barrientos et al., 2003; O’Keefe et al., 2003; 
Helleet al., 2006); scytovirin (SVN) (Bokesch et al., 2003), Microcystis viridis lectin (MVL) 
(Bewley et al., 2004), and griffithsin (GRFT) (Mori et al., 2005; Ziółkowska et al., 2006) exhibit 
significant activity against human immunodeficiency virus (HIV) and other enveloped 
viruses, which makes them particularly promising targets for the development as novel 
antiviral drugs (De Clercq, 2005; Reeves & Piefer, 2005) 
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Fig. 1. Representation of bacterial lectins binding to the host cell (left) and specific lectins, 
used as drug interfering with this bacteria-host interaction (right) 
Keyaerts et al., (2007) described the antiviral activity of plant lectins with specificity for 
different glycan structures against the severe acute respiratory syndrome coronavirus 
(SARS-CoV) and the feline infectious peritonitis virus (FIPV) in vitro. The SARS-CoV 
emerged in 2002 as an important cause of severe lower respiratory tract infection in humans, 
and FIPV infection causes a chronic and often fatal peritonitis in cats. A unique collection of 
33 plant lectins with different specificities were evaluated. The plant lectins possessed 
marked antiviral properties against both coronaviruses with EC50 values in the lower 
microgram/ml range (middle nanomolar range), being non-toxic (CC50) at 50–100 μg/ml. 
The strongest anti-coronavirus activity was found predominantly among the mannose-
binding lectins. In addition, a number of galactose-, N-acetylgalactosamine-, glucose-, and 
N-acetylglucosamine-specific plant agglutinines exhibited anti-coronaviral activity. A 
significant correlation (with an r-value of 0.70) between the EC50 values of the 10 mannose-
specific plant lectins effective against the two coronaviruses was found. In contrast, little 
correlation was seen between the activities of other types of lectins. Two targets of possible 
antiviral intervention were identified in the replication cycle of SARS-CoV. The first target is  
located early in the replication cycle, most probably viral attachment, and the second target 
is located at the end of the infectious virus cycle (Keyaerts et al., 2007). 
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The carbohydrate binding profile of the red algal lectin KAA-2 from Kappaphycus alvarezii 
was studied by Sato et al (2011). They tested the anti-influenza virus activity of KAA-2 
against various strains including the recent pandemic H1N1-2009 influenza virus. KAA-2 
inhibited infection of various influenza strains with EC50s of low nanomolar levels. 
Immunofluorescence microscopy using an anti-influenza antibody demonstrated that the 
antiviral activity of KAA-2 was exerted by interference with virus entry into host cells. This 
mechanism was further confirmed by evidence of direct binding of KAA-2 to a viral 
envelope protein, hemagglutinin (HA), using an ELISA assay. These results indicate that 
this lectin could be a useful antiviral agent (Sato Y et al., 2011). 
5. Antifungal effects of lectins 
Despite the large numbers of lectins and hemagglutinins that have been purified, only a few 
of them manifested antifungal activity (Table 5). The expression of Gastrodia elata lectins in 
the vascular cells of roots and stems was strongly induced by the fungus Trichoderma viride, 
indicating that lectin is an important defense protein in plants (Sá et al., 2009). Following 
insertion of the precursor gene of stinging nettle isolectin I into tobacco, the germination of 
spores of Botrytis cinerea, Colletotrichum lindemuthianum, and T. viride was significantly 
reduced (Does et al., 1999). Thus, lectins may be introduced into plants to protect them from 
fungal attack. 
Plant lectins can neither bind to glycoconjugates on the fungal membranes nor penetrate the 
cytoplasm owing to the cell wall barrier. It is not likely that lectins directly inhibit fungal 
growth by modifying fungal membrane structure and/or permeability. However, there may 
be indirect effects produced by the binding of lectins to carbohydrates on the fungal cell 
wall surface. Chitinase-free chitin-binding stinging nettle (Urtica dioica lectin) impeded 
fungal growth. Cell wall synthesis was interrupted because of attenuated chitin synthesis 
and/or deposition (Van Parijs et al., 1991). The effects of nettle lectin on fungal cell wall and 
hyphal morphology suggest that the nettle lectin regulates endomycorrhizal colonization of 
the rhizomes. Severa1 other plant lectins inhibit fungal growth. The first group includes 
small chitin-binding merolectins with one chitin-binding domain, e.g., hevein from rubber 
tree latex (Van Parijs et al., 1991) and chitin-binding polypeptide from Amaranthus caudatus 
seeds (Broekaert et al., 1992). The only plant lectins that can be considered as fungicidal 
proteins are the chimerolectins belonging to the class I chitinases. However, the antifungal 
activity of these proteins is ascribed to their catalytic domain. 
6. Lectins and the immune system 
To initiate immune responses against infection, the surface receptors on antigen 
presenting cells must recognise the corresponding molecules on infectious agents. 
Pattern recognition receptors (PRR) which include C-type lectin like receptor (CLR) 
recognise and interact with carbohydrate moieties of many pathogens. Despite the 
presence of a highly conserved domain, C-type lectins are functionally diverse and have 
been implicated in various processes including cell adhesion, tissue integration and 
remodelling, platelet activation, complement activation, pathogen recognition, 
endocytosis, and phagocytosis.  
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Natural source of lectin Fungal species inhibited Sugar specificity Reference 
Amaranthus viridis  
(Green Amaranth) seeds 
Botrytis cinerea,  
Fusarium oxysporum 
Asialofetuin, 
fetuin,  
T-antigen, N-
acetyl-d-
lactosamine, 
N-acetyl-d-
galactosamine 
Kaur et 
al.2006 
Astragalus mongholicus  
(huangqi) roots 
Borrytis cinerea, 
Colletrichum sp., 
Droschslara turia,  
Fusarium oxysporum 
d-galactose, 
lactose 
Yan et 
al.2005 
Capparis spinosa (caper) seeds Valsa mali D(+)galactose,  
ǂ-lactose,  
raffinose, 
rhamnose,  
L(+)-arabinose, 
D(+)glucosamine 
Lam et 
al.2009 
Capsicum frutescens  
(red cluster pepper) seeds 
Aspergillus flavus, 
Fusarium moniliforme 
d-mannose, 
glucose 
Ngai and 
Ng 2007 
Curcuma amarissima Roscoe  
(wei ji ku jiang-huang) 
Rhizomes 
Colectrotrichum cassiicola, 
Exserohilum turicicum, 
Fusarium oxysporum 
Not found Kheeree et 
al. 2010 
Dendrobium findlayanum  
(orchid) pseudobulbs 
Alternaria alternata, 
Colletrichum sp. 
Not found Sattayasai 
et al. 2009 
Phaselous vulgaris cv “ 
flageolet bean” seeds 
Mycosphaerella arachidicola Not found Xia and Ng 
2005 
Phaselous vulgaris cv  
“French bean 35” seeds 
Valsa mali Not found Lam and 
Ng 2010 
Phaseolus coccineus seeds Gibberalla sanbinetti, 
Helminthosporium maydis, 
Rhizoctonia solani, 
Sclerotinia sclerotiorum 
Sialic acid Chen et 
al.2009 
Phaseolus vulgaris cv  
“red kidney bean” seeds 
Coprinus comatus, 
Fusarium oxysporum, 
Rhizoctonia solani 
Lactoferrin, 
ovalbumin, 
thyroglobulin 
Ye et al. 
2001 
Pouteria torta  
(pouteria trees/eggfruits) 
seeds 
Saccharomyces carevisiae, C. 
musae, Fusarium 
oxysporum 
Fetuin, 
asialofetuin, 
heparin, 
orosomucoid, 
ovoalbumin 
Boleti et 
al.2007 
Talisia esculenta (pitomba) 
seeds 
Microsporum canis d-mannose Pinheiro et 
al. 2009 
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Natural source of lectin Fungal species inhibited Sugar specificity Reference 
Withania somnifera 
(Ashwagandha/Indian 
ginseng/Winter 
cherry/Ajagandha/Kanaje 
Hindi/Amukkuram) leaves 
Fusarium moniliforme, 
Macrophomina phaseolina 
Not found Ghosh 
2009 
Zea mays (maize) endosperm Aspergillus flavus D(+)galactose Baker et 
al.,2009 
Table 6. Examples of lectins with antifungal activity, Source: Lam and Ng, 2011 
6.1 Mannose Receptor 
The MR binds a broad array of microorganisms, including Candida albicans, Pneumocystis 
carinii, Leishmania donovani, Mycobacterium tuberculosis, and capsular polysaccharides of 
Klebisella pneumoniae and Streptococcus pneumonia (Chakraborty et al., 2001; Ezekowitz et al., 
1991; Marodi et al., 1991; O’Riordan et al., 1995; Schlesinger, 1993; Zamze et al., 2002). The 
receptor recognises mannose, fucose or N-acetylglucosamine sugar residues on the surfaces 
of these microorganisms (Largent et al., 1984) and carbohydrate recognition is mediated by 
CTLDs 4–8 (Taylor et al., 1992). The MR has been implicated in the phagocytic uptake of 
pathogens, but there are limited examples actually demonstrating MR-dependent 
phagocytosis.  
6.2 Dectin-1 
Dectin-1 is a type II transmembrane protein that is classified as a Group V non-classical C-
type lectin and lacks the conserved residues involved in the ligation of calcium that are 
usually required to co-ordinate carbohydrate binding. Dectin-1 was initially identified as a 
dendritic cell specific receptor that modulates T cell function through recognition of an 
unidentified ligand (Ariizumi et al., 2000; Grunebach et al., 2002). It was subsequently 
reidentified as a receptor for ǃ-glucans, which are carbohydrate polymers found primarily 
in the cell walls of fungi, but also in plants and some bacteria (Brown and Gordon, 2001, 
2003). Dectin-1 can recognise a number of fungal species, including C. albicans, P. carinii, 
Saccharomyces cerevisiae, Coccidioides posadasii and Aspergillus fumigatus (Brown et al., 2003; 
Gersuk et al., 2006; Saijo et al., 2007; Steele et al., 2003, 2005; Taylor et al., 2007; Viriyakosol et 
al., 2005).The ligation of Dectin-1 also triggers intracellular signalling resulting in a variety 
of cellular responses, including phagocytosis. 
6.3 DC-SIGN (CD209) 
DC-SIGN is a type II transmembrane protein that is classified as a Group II C-type lectin. 
DC-SIGN was originally identified as a receptor for intercellular adhesion molecule-3 
(ICAM-3) that facilitates DC-mediated T-cell proliferation and binds HIV-1 (Geijtenbeek et 
al., 2000a, b). It has since been reported that the receptor interacts with a range of pathogens, 
including M. tuberculosis, C. albicans, Helicobacter pylori, Schistosoma mansoni and A. fumigatus 
(Appelmelk et al., 2003; Cambi et al., 2008; Geijtenbeek et al., 2000b, 2003; Serrano-Gomez et 
al., 2004; Tailleux et al., 2003; van Die et al., 2003). There have been no reports of a 
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mechanism for DC-SIGN mediated phagocytosis. However, activation of DC-SIGN triggers 
Rho-GTPase (Hodges et al., 2007) making it conceivable that Rho could be involved in 
phagocytosis mediated by this receptor.  
6.4 Mannose-binding lectin (MBL) 
Mannose-binding lectin (MBL) is a Group III C-type lectin belonging to the collectins 
(Holmskov et al., 2003), which are a group of soluble oligomeric proteins containing 
collagenous regions and CTLDs. MBL is secreted into the blood stream as a large multimeric 
complex and is primarily produced by the liver, although other sites of production, such as 
the intestine, have been proposed (Uemura et al., 2002). It recognises carbohydrates such as 
mannose, glucose, l-fucose, N-acetyl-mannosamine (ManNAc), and N-acetyl-glucosamine 
(GlcNAc). Oligomerisation of MBL enables high avidity binding to repetitive carbohydrate 
ligands, such as those present on a variety of microbial surfaces, including E. coli, Klebisella 
aerogenes, Neisseria meningitides, Staphylococcus aureus, S. pneumoniae, A. fumigatus and C. 
albicans (Davies et al., 2000; Neth et al., 2000; Schelenz et al., 1995; Tabona et al., 1995; van 
Emmerik et al., 1994).MBL has also been proposed to function directly as an opsonin by 
binding to carbohydrates on pathogens and then interacting with MBL receptors on 
phagocytic cells, promoting microbial uptake and stimulating immune responses (Kuhlman 
et al., 1989). It was shown in a recent study that MBL modifies cytokine responses through a 
novel cooperation with TLR2/6 in the phagosome (Ip et al., 2008). 
7. Lectins and drug delivery 
The concept of lectin-mediated specific drug delivery was proposed by Woodley and 
Naisbett in 1988 (Bies et al., 2004). Delivery of targeted therapeutics via direct and reverse 
drug delivery systems (DDS) to specific sites provides numerous advantages over 
traditional non-targeted therapeutics (Rek et al., 2009). Targeted drug delivery increases the 
efficacy of treatment by enhancing drug exposure to targeted sites while limiting side effects 
of drugs on normal and healthy tissues (Rek et al., 2009). Furthermore, specific drug 
delivery increases the uptake and internalization of therapeutics that have reduced cellular 
permeability (Rek et al., 2009). Lectin based drug-targeting can be done in two ways. In the 
first approach, carbohydrate moieties form a part of DDS. The carbohydrate tag drives the 
drug to the endogenous lectins present on the cell surface. In the second approach, lectins 
are present on the drug surface and it interacts with the glycosylated surfaces of the cells 
(Gabor et al., 2004). Considering the fact that epithelial cells contain a thin layer of mucus 
which has mucins that are highly glycosylated proteins, the lectin-encapsulated drug 
strategy offers great potential. As non-specific interactions are susceptible to changes in pH 
and to interactions with food digesta, which probably reduce the mucoadhesive effect, 
specific mucoadhesiva of the second generation seem to be preferable. The second target is 
the glycocalyx of the absorptive epithelium. In case of identical oligosaccharide structures of 
the mucin and the glycocalyx, partitioning of the formulation to the cell surface is facilitated 
due to full reversibility of the mucin–lectin interaction. In case of lectin-matching 
carbohydrates only at the glycocalyx, the formulation has to penetrate the mucuos layer. 
Both pathways result in fixation of the drug delivery system closer to the site of absorption. 
That way cytoadhesion will increase the concentration gradient between the extracellular 
and intracellular compartment, which facilitates at least passive diffusion of the drug into 
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the cell. The third target is represented by glycosylated receptors at the cell membrane. The 
binding of some lectins, such as WGA to the EGF-receptor, induces active receptor mediated 
endocytosis, which can improve cytoinvasion of prodrugs as well as nanoscaled carrier 
systems (Gabor, 2004).  
In an approach towards pulmonary delivery, lectinised liposomes (130–170 nm in diameter) 
were screened for binding to alveolar type II epithelial cells (Bruck et al., 2001). As 
compared to plain liposomes, the binding to A549 cells increased 6–11-fold upon surface 
modification with wheat germ agglutinin (WGA), Concanavalin A (ConA) or soybean 
agglutinin. The binding was not affected by a synthetic lung surfactant and no cytotoxic 
effect of the free lectins or the lectinised liposomes was observed. Upon incubation with 
primary cultured human alveolar epithelial cells, which exhibit barrier functions, the WGA-
liposomes were not only bound but also taken up into the cells. In search for non-viral 
vectors for gene therapy of cystic fibrosis and as a basis for lectin-mediated gene transfer, 32 
lectins were screened for binding and uptake into living human airway epithelium (Yi et al., 
2001). Whereas ConA was internalised within 1 h, the lectins from Erythrina cristagalli and 
Glycine max, peanut lectin, and Jacalin were taken up into the epithelium within 4 h. The 
endocytosis of WGA was minimal even after 4 h. Irrespective of the specificity of the lectin–
carbohydrate interaction; the internalised lectins exhibited a non-selective binding pattern on 
the epithelium. Only peanut lectin bound to subpopulations of ciliated and non-ciliated cells. 
Owing to their remarkable specificities, plant lectins with affinities for the carbohydrates on 
microbial cell surface are already well characterised. Given the potential of porphyrins to act 
as antimicrobials it is pertinent to ask whether lectins could be used in vivo to specifically 
deliver porphyrins into pathogenic microbial cells, thereby improving the efficacy of the 
treatment, reducing the concentration of the drug required to be introduced into the system 
and thereby reducing the possible side-effects. In particular, lectins could be successful oral 
and mucosal drug delivery agents. Not only are a large number of lectins part of our 
everyday diet, but also several of them are known to survive the harsh conditions of human 
gastro-intestinal tract. Similarly, attempts have been made to use lectins in ocular drug 
delivery. Specific hydrophobic binding sites on lectins provide the ideal opportunity to 
expand the use of these molecules in targeted therapy (Komath et al., 2006). 
8. Conclusions 
Lectins are ubiquitous in nature and have garnered much attention due to specificity of its 
interaction with the carbohydrates. Glycosylation is a key step in many cellular processes 
and with more reports about the change in cell-surface carbohydrates in different 
pathological conditions, research about exploiting lectins as a therapeutic tool is now at the 
forefront. Lectins are now routinely used in the identification and purification of 
glycoproteins. Their use in blood typing as well as in clinical diagnostics is well established. 
Many lectins show antibacterial, antiviral or antifungal activities in-vitro. However, clinical 
trials need to be done for establishing their therapeutic effect and optimising their dosage 
delivery. As microbes use their surface lectins for attachment to the host tissue, 
dietary/therapeutic lectins may interfere in this interaction. Thus lectins can be used anti-
adhesion agents and prevent the colonization of the microbe and hence the establishment of 
the infection. In the immune system, endogenous lectins play a role in ligand recognition 
and hence are an important component of the host’s defense against microbes. Given their 
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ability to specifically target different cell types, they have always been looked upon as 
useful candidates for targeted drug delivery. Research utilizing lectins as carriers of 
monoclonal antibodies or specific chemotherapeutic agents has been conducted. Alongwith 
the beneficial effect, lectins have been reported to have caused severe allergic reactions. 
Most of the information on the acute toxicity of lectins in humans has been derived from 
observations of incidences of accidental poisoning. Since no experimental data is available to 
show the possible adverse effects of lectins on humans but can be inferred from experiments 
with laboratory animals. Although results obtained with mice, rats or pigs cannot simply be 
extrapolated to humans, the observed effects on the gut and other organs of these animals 
demonstrate the possible toxicity of the lectins. Thus lectin-based therapeutics for combating 
infections is very promising owing to its highly selective nature, provided the dosage is well 
below the toxic limits.  
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